glp-1 lasker The transformative breakthroughs in research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP-1s are building a reputation

Selenium nanoparticles coated with ph responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer

J Inherit Metab Dis 33:539546 Stanley CA (1995) Carnitine disorders

Rivera I

Ongoing Alzheimers Research Clinical trials are currently exploring GLP-1 medications in patients with mild cognitive impairment and Alzheimers disease

Cardiometabolic area: potential effects and cautions Analyses have been published in cardiology contexts (for example, after acute myocardial infarction), where associations with improvements in some outcomes have been observed

For the SRB assay, cells were seeded (5,000 cells per well) in a 96-well plate and then treated with the indicated drugs